{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:14:40Z","timestamp":1791360880420,"version":"4.3.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science, and Technology of Japan","doi-asserted-by":"crossref","award":["20K09827"],"award-info":[{"award-number":["20K09827"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s10384-025-01201-7","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T23:14:03Z","timestamp":1747350843000},"page":"624-632","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The relationship between aldosterone-induced retinal ganglion cell loss, blood pressure, and intraocular pressure"],"prefix":"10.1007","volume":"69","author":[{"given":"Ayaka","family":"Edo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Hirooka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Onoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Kiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,16]]},"reference":[{"key":"1201_CR1","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1016\/S0140-6736(17)31469-1","volume":"390","author":"JB Jonas","year":"2017","unstructured":"Jonas JB, Aung T, Bourne RR, Bron AM, Ritch R, Panda-Jonas S. Glaucoma. The Lancet. 2017;390:2183\u201393.","journal-title":"The Lancet"},{"issue":"9","key":"1201_CR2","first-page":"e144","volume":"2021","author":"GBD 2019 Blindness and Vision Impairment Collaborators","year":"2021","unstructured":"GBD 2019 Blindness and Vision Impairment Collaborators. Vision loss expert group of the global burden of disease study causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the global burden of disease study. Lancet Glob Health. 2021;2021(9):e144-60.","journal-title":"Lancet Glob Health."},{"key":"1201_CR3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","volume":"130","author":"AGIS investigators","year":"2000","unstructured":"AGIS investigators. The advanced glaucoma intervention study (AGIS):7 The relationship between control of intraocular pressure and visual field deterioration The AGIS Investigators. Am J Ophthalmol. 2000;130:429\u201340.","journal-title":"Am J Ophthalmol."},{"key":"1201_CR4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10384-022-00970-9","volume":"67","author":"Y Kiuchi","year":"2023","unstructured":"Kiuchi Y, Inoue T, Shoji N, Nakamura M, Tanito M, Inoue K, et al. The Japan Glaucoma Society guidelines for glaucoma 5th edition. Jpn J Ophthalmol. 2023;67:189\u2013254.","journal-title":"Jpn J Ophthalmol."},{"key":"1201_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.optom.2016.02.003","volume":"10","author":"CW McMonnies","year":"2017","unstructured":"McMonnies CW. Glaucoma history and risk factors. J Optom. 2017;10:71\u20138.","journal-title":"J Optom"},{"key":"1201_CR6","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.ajo.2014.05.029","volume":"158","author":"D Zhao","year":"2014","unstructured":"Zhao D, Cho J, Kim MH, Guallar E. The association of blood pressure and primary open-angle glaucoma: a meta-analysis. Am J Ophthalmol. 2014;158:615-27.e9.","journal-title":"Am J Ophthalmol"},{"key":"1201_CR7","doi-asserted-by":"publisher","first-page":"e000798","DOI":"10.1136\/bmjophth-2021-000798","volume":"6","author":"R Nislawati","year":"2021","unstructured":"Nislawati R, Zainal ATF, Ismail A, Waspodo N, Kasim F, Gunawan AMAK. Role of hypertension as a risk factor for open-angle glaucoma: a systematic review and meta-analysis. BMJ Open Ophthalmol. 2021;6:e000798.","journal-title":"BMJ Open Ophthalmol."},{"key":"1201_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/endocr\/bqac201","volume":"164","author":"T Higashide","year":"2022","unstructured":"Higashide T, Hirooka K, Kometani M, Sugiyama K. Aldosterone as a possible contributor to eye diseases. Endocrinology. 2022;164:1\u201312.","journal-title":"Endocrinology"},{"key":"1201_CR9","doi-asserted-by":"publisher","first-page":"e711","DOI":"10.1038\/cddis.2013.240","volume":"4","author":"E Nitta","year":"2013","unstructured":"Nitta E, Hirooka K, Tenkumo K, Fujita T, Nishiyama A, Nakamura T, et al. Aldosterone: a mediator of retinal ganglion cell death and the potential role in the pathogenesis in normal-tension glaucoma. Cell Death Dis. 2013;4:e711.","journal-title":"Cell Death Dis"},{"key":"1201_CR10","doi-asserted-by":"publisher","first-page":"147032031879500","DOI":"10.1177\/1470320318795001","volume":"19","author":"Y Takasago","year":"2018","unstructured":"Takasago Y, Hirooka K, Nakano Y, Kobayashi M, Ono A. Elevated plasma aldosterone levels are associated with a reduction in retinal ganglion cell survival. J Renin Angiotensin Aldosterone Syst. 2018;19:147032031879500.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"1201_CR11","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.exer.2011.12.012","volume":"96","author":"Y Liu","year":"2012","unstructured":"Liu Y, Hirooka K, Nishiyama A, Lei B, Nakamura T, Itano T, et al. Activation of the aldosterone\/mineralocorticoid receptor system and protective effects of mineralocorticoid receptor antagonism in retinal ischemia-reperfusion injury. Exp Eye Res. 2012;96:116\u201323.","journal-title":"Exp Eye Res"},{"key":"1201_CR12","doi-asserted-by":"publisher","first-page":"E7738","DOI":"10.1503\/cmaj.161486","volume":"189","author":"GA Kline","year":"2017","unstructured":"Kline GA, Prebtani APH, Leung AA, Schiffrin EL. Primary aldosteronism: a common cause of resistant hypertension. CMAJ. 2017;189:E7738.","journal-title":"CMAJ"},{"key":"1201_CR13","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1001\/jama.1965.03090030022005","volume":"193","author":"JW Conn","year":"1965","unstructured":"Conn JW, Cohen EL, Rovner DR, Nesbit RM. Normokalemic primary aldosteronism: a detectable cause of curable \u201cessential\u201d hypertension. JAMA. 1965;193:200\u20136.","journal-title":"JAMA"},{"key":"1201_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/M20-0065","volume":"173","author":"JM Brown","year":"2020","unstructured":"Brown JM, Siddiqui M, Calhoun DA, Carey RM, Hopkins PN, Williams GH, et al. The unrecognized prevalence of primary aldosteronism. Ann Intern Med. 2020;173:10\u201320.","journal-title":"Ann Intern Med"},{"key":"1201_CR15","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1080\/02713683.2022.2029907","volume":"47","author":"Y Wada","year":"2022","unstructured":"Wada Y, Higashide T, Sakaguchi K, Nagata A, Hirooka K, Sugiyama K. Compromised blood flow in the optic nerve head after dystemic administration of aldosterone in rats: a possible rat model of retinal ganglion cell loss. Curr Eye Res. 2022;47:777\u201385.","journal-title":"Curr Eye Res"},{"key":"1201_CR16","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3390\/antiox11040610","volume":"11","author":"K Hirooka","year":"2022","unstructured":"Hirooka K, Kiuchi Y. The retinal renin-angiotensin-aldosterone system: implications for glaucoma. Antioxidants. 2022;11:610.","journal-title":"Antioxidants"},{"key":"1201_CR17","doi-asserted-by":"publisher","first-page":"4035","DOI":"10.3390\/ijms25074035","volume":"25","author":"SH Ksiazek","year":"2024","unstructured":"Ksiazek SH, Hu L, And\u00f2 S, Pirklbauer M, S\u00e4emann MD, Ruotolo C, et al. Renin\u2013angiotensin\u2013aldosterone system: from history to practice of a secular topic. Int J Mol Sci. 2024;25:4035.","journal-title":"Int J Mol Sci"},{"key":"1201_CR18","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1096\/fj.09-154344","volume":"24","author":"M Zhao","year":"2010","unstructured":"Zhao M, Valamanesh F, Celerier I, Savoldelli M, Jonet L, Jeanny JC, et al. The neuroretina is a novel mineralocorticoid target: aldosterone up-regulates ion and water channels in M\u00fcller glial cells. FASEB J. 2010;24:3405\u201315.","journal-title":"FASEB J"},{"key":"1201_CR19","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1161\/HYPERTENSIONAHA.111.188136","volume":"59","author":"D Deliyanti","year":"2012","unstructured":"Deliyanti D, Miller AG, Tan G, Binger KJ, Samson AL, Wilkinson-Berka JL. Neovascularization is attenuated with aldosterone synthase inhibition in rats with retinopathy. Hypertension. 2012;59:607\u201313.","journal-title":"Hypertension"},{"key":"1201_CR20","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1167\/iovs.16-21001","volume":"58","author":"M Kobayashi","year":"2017","unstructured":"Kobayashi M, Hirooka K, Ono A, Nakano Y, Nishiyama A, Tsujikawa A. The relationship between the renin-angiotensin\u2013aldosterone system and NMDA receptor-mediated signal and the prevention of retinal ganglion cell death. Invest Ophthalmol Vis Sci. 2017;58:1397.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1201_CR21","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1167\/iovs.09-4107","volume":"51","author":"K Fukuda","year":"2010","unstructured":"Fukuda K, Hirooka K, Mizote M, Nakamura T, Itano T, Shiraga F. Neuroprotection against retinal ischemia\u2013reperfusion injury by blocking the angiotensin II type 1 receptor. Invest Ophthalmol Vis Sci. 2010;51:3629.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1201_CR22","doi-asserted-by":"publisher","first-page":"e0242090","DOI":"10.1371\/journal.pone.0242090","volume":"15","author":"Y Ohshima","year":"2020","unstructured":"Ohshima Y, Higashide T, Sakaguchi K, Sasaki M, Udagawa S, Ohkubo S, et al. The association of primary aldosteronism with glaucoma-related fundus abnormalities. PLoS ONE. 2020;15:e0242090.","journal-title":"PLoS ONE"},{"key":"1201_CR23","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","volume":"69","author":"S Monticone","year":"2017","unstructured":"Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, Buffolo F, et al. Prevalence and clinical manifestations of primary aldosteronismencountered in primary care practice. J Am Coll Cardiol. 2017;69:1811\u201320.","journal-title":"J Am Coll Cardiol"},{"key":"1201_CR24","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/00061198-200408000-00010","volume":"13","author":"P Mitchell","year":"2004","unstructured":"Mitchell P, Lee AJ, Rochtchina E, Wang JJ. Open-angle glaucoma and systemic hypertension: the Blue Mountains Eye Study. J Glaucoma. 2004;13:319\u201326.","journal-title":"J Glaucoma"},{"key":"1201_CR25","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ajo.2024.09.014","volume":"269","author":"K Hirooka","year":"2024","unstructured":"Hirooka K, Higashide T, Sakaguchi K, Udagawa S, Sugiyama K, Oki K, et al. Prevalence of normal-tension glaucoma in patients with primary aldosteronism. Am J Ophthalmol. 2024;269:339\u201345.","journal-title":"Am J Ophthalmol"},{"key":"1201_CR26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4103\/1673-5374.344831","volume":"18","author":"WC Shen","year":"2023","unstructured":"Shen WC, Huang BQ, Yang J. Regulatory mechanisms of retinal ganglion cell death in normal tension glaucoma and potential therapies. Neural Regen Res. 2023;18:87\u201393.","journal-title":"Neural Regen Res"},{"key":"1201_CR27","first-page":"10","volume":"2021","author":"EYC Kang","year":"1948","unstructured":"Kang EYC, Liu PK, Wen YT, Quinn PMJ, Levi SR, Wang NK, et al. Role of oxidative stress in ocular diseases associated with retinal ganglion cells degeneration. Antioxidants. 1948;2021:10.","journal-title":"Antioxidants."},{"key":"1201_CR28","doi-asserted-by":"publisher","first-page":"4099","DOI":"10.1167\/iovs.11-9167","volume":"53","author":"T Fujita","year":"2012","unstructured":"Fujita T, Hirooka K, Nakamura T, Itano T, Nishiyama A, Nagai Y, et al. Neuroprotective effects of angiotensin II type 1 receptor (AT1-R) blocker via modulating AT1-R signaling and decreased extracellular glutamate levels. Invest Ophthalmol Vis Sci. 2012;53:4099.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1201_CR29","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s10384-018-0595-4","volume":"62","author":"A Ono","year":"2018","unstructured":"Ono A, Hirooka K, Nakano Y, Nitta E, Nishiyama A, Tsujikawa A. Gene expression changes in the retina after systemic administration of aldosterone. Jpn J Ophthalmol. 2018;62:499\u2013507.","journal-title":"Jpn J Ophthalmol"},{"key":"1201_CR30","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s10384-012-0204-x","volume":"57","author":"Y Ozawa","year":"2013","unstructured":"Ozawa Y, Yuki K, Yamagishi R, Tsubota K, Aihara M. Renin\u2013angiotensin system involvement in the oxidative stress-induced neurodegeneration of cultured retinal ganglion cells. Jpn J Ophthalmol. 2013;57:126\u201332.","journal-title":"Jpn J Ophthalmol"},{"key":"1201_CR31","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1177\/1470320314566018","volume":"16","author":"A White Jr","year":"2015","unstructured":"White A Jr, Heller JP, Leung J, Tassoni A, Martin KR. Retinal ganglion cell neuroprotection by an angiotensin II blocker in an ex vivo retinal explant model. J Renin Angiotensin Aldosterone Syst. 2015;16:1193\u2013201.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"1201_CR32","doi-asserted-by":"publisher","first-page":"e0285039","DOI":"10.1371\/journal.pone.0285039","volume":"18","author":"K Hirooka","year":"2023","unstructured":"Hirooka K, Oki K, Ogawa-Ochiai K, Nakaniida Y, Onoe H, Kiuchi Y. Blood flow in the optic nerve head in patients with primary aldosteronism. PLoS ONE. 2023;18:e0285039.","journal-title":"PLoS ONE"},{"key":"1201_CR33","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/j.1476-5381.2012.02194.x","volume":"168","author":"N Toda","year":"2013","unstructured":"Toda N, Nakanishi S, Tanabe S. Aldosterone affects blood flow and vascular tone regulated by endothelium-derived NO: therapeutic implications. Br J Pharmacol. 2013;168:519\u201333.","journal-title":"Br J Pharmacol"},{"key":"1201_CR34","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1507\/endocrj.K09E-014","volume":"56","author":"K Tsuchiya","year":"2009","unstructured":"Tsuchiya K, Yoshimoto T, Hirata Y. Endothelial dysfunction is related to aldosterone excess and raised blood pressure. Endocr J. 2009;56:553\u20139.","journal-title":"Endocr J"},{"issue":"Suppl 1","key":"1201_CR35","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/S0039-6257(05)80073-6","volume":"39","author":"T Sugiyama","year":"1995","unstructured":"Sugiyama T, Moriya S, Oku H, Azuma I. Association of endothelin-1 with normal tension glaucoma: clinical and fundamental studies. Surv Ophthalmol. 1995;39(Suppl 1):S49-56.","journal-title":"Surv Ophthalmol"},{"key":"1201_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1600-0420.1997.tb00448.x","volume":"75","author":"M Cellini","year":"1997","unstructured":"Cellini M, Possati GL, Profazio V, Sbrocca M, Caramazza N, Caramazza R. Color Doppler imaging and plasma levels of endothelin-1 in low-tension glaucoma. Acta Ophthalmol Scand. 1997;75:11\u20133.","journal-title":"Acta Ophthalmol Scand"},{"key":"1201_CR37","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0895-7061(01)02291-9","volume":"15","author":"JB Park","year":"2002","unstructured":"Park JB, Schiffrin EL. Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: role of endothelin-1. Am J Hypertens. 2002;15:164\u20139.","journal-title":"Am J Hypertens"},{"key":"1201_CR38","doi-asserted-by":"publisher","first-page":"4803","DOI":"10.3390\/ijms23094803","volume":"23","author":"F Bioletto","year":"2022","unstructured":"Bioletto F, Bollati M, Lopez C, Arata S, Procopio M, Ponzetto F, et al. Primary aldosteronism and resistant hypertension: a pathophysiological insight. Int J Mol Sci. 2022;23:4803.","journal-title":"Int J Mol Sci"},{"key":"1201_CR39","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1189\/jlb.0907592","volume":"83","author":"G Woller","year":"2008","unstructured":"Woller G, Brandt E, Mittelst\u00e4dt J, Rybakowski C, Petersen F. Platelet factor 4\/CXCL4-stimulated human monocytes induce apoptosis in endothelial cells by the release of oxygen radicals. J Leukoc Biol. 2008;83:936\u201345.","journal-title":"J Leukoc Biol"},{"key":"1201_CR40","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S0079-6123(08)01134-5","volume":"173","author":"M Seki","year":"2008","unstructured":"Seki M, Lipton SA. Targeting excitotoxic\/free radical signaling pathways for therapeutic intervention in glaucoma. Prog Brain Res. 2008;173:495\u2013510.","journal-title":"Prog Brain Res"},{"key":"1201_CR41","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1038\/cdd.2013.91","volume":"20","author":"K Namekata","year":"2013","unstructured":"Namekata K, Kimura A, Kawamura K, Guo X, Harada C, Tanaka K, et al. Dock3 attenuates neural cell death due to NMDA neurotoxicity and oxidative stress in a mouse model of normal tension glaucoma. Cell Death Differ. 2013;20:1250\u20136.","journal-title":"Cell Death Differ"},{"key":"1201_CR42","doi-asserted-by":"publisher","first-page":"818139","DOI":"10.3389\/fmed.2022.818139","volume":"9","author":"A Edo","year":"2022","unstructured":"Edo A, Ibrahim DG, Hirooka K, Toda R, Kamaruddin MI, Kawano R, et al. Dietary vitamins A, C, and potassium intake is associated with narrower retinal venular caliber. Front Med (Lausanne). 2022;9:818139.","journal-title":"Front Med (Lausanne)."},{"key":"1201_CR43","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/hr.2013.124","volume":"37","author":"T Hattori","year":"2014","unstructured":"Hattori T, Murase T, Sugiura Y, Nagasawa K, Takahashi K, Ohtake M, et al. Effects of salt status and blockade of mineralocorticoid receptors on aldosterone-induced cardiac injury. Hypertens Res. 2014;37:125\u201333.","journal-title":"Hypertens Res"},{"key":"1201_CR44","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.coemr.2019.07.001","volume":"8","author":"N Yozamp","year":"2019","unstructured":"Yozamp N, Vaidya A. The prevalence of primary aldosteronism and evolving approaches for treatment. Curr Opin Endocr Metab Res. 2019;8:30\u20139.","journal-title":"Curr Opin Endocr Metab Res."}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-025-01201-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10384-025-01201-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-025-01201-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T15:42:42Z","timestamp":1757173362000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10384-025-01201-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1201"],"URL":"https:\/\/doi.org\/10.1007\/s10384-025-01201-7","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,16]]},"assertion":[{"value":"21 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A. Edo, Grants or contracts (Alcon); K. Hirooka, None; H. Onoe, None; Y. Kiuchi, Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Santen, Senju, AMO), Support for attending meetings and\/or travel (HOYA, Otsuka).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}